HealthVerity eXOs
powered by Medeloop
Rapid and transparent RWE generation without the complexity or data analysis delays
Traditional real-world data analysis requires translating research questions into code sets and cohort definitions, sourcing and preparing data, building analytic workflows and documenting methodology.
These steps are time-intensive and often require specialized expertise.
HealthVerity eXOs is an agentic AI platform built for teams that need faster answers with transparency and scientific rigor. It handles the heavy lifting while giving users full visibility and control over AI agents throughout the research process, from query to outcome.
Faster critical decisions
Rapid iteration – run and refine analyses in minutes.
Confident results
Transparent steps and cohort logic; detailed results.
Insights in every hand
Democratized platform, unlimited users and questions, one flat-fee.
Built upon HealthVerity Marketplace, the nation’s leading healthcare and consumer data ecosystem, HealthVerity eXOs augments RWE teams with an agentic AI evidence studio that turns plain English questions into transparent analyses in minutes with step-by-step logic and auditable programming code. By accelerating RWE analyses, such as feasibility, prevalence/incidence, adherence and time-to-event analyses, teams can reliably perform essential research with increased confidence and speed at a fraction of the cost.
Cohort Feasibility & Description
Define populations and understand size, demographics, comorbidities and other characteristics
Epidemiology
Estimate prevalence and incidence rates in the data set
Comparative Effectiveness
Contrast effectiveness and safety outcomes across cohorts for evidence generation, including mortality and hospitalizations
Adherence & Persistence
Compute proportion of days covered and related metrics, compare subgroups
Time-to-Event
Measure time to initiation, discontinuation, change of therapy, and other key milestones for patient cohorts
Cohort Feasibility & Description
Define populations and understand size, demographics, comorbidities and other characteristics
Epidemiology
Estimate prevalence and incidence rates in the data set
Comparative Effectiveness
Contrast effectiveness and safety outcomes across cohorts for evidence generation, including mortality and hospitalizations
Adherence & Persistence
Compute proportion of days covered and related metrics, compare subgroups
Time-to-Event
Measure time to initiation, discontinuation, change of therapy, and other key milestones for patient cohorts